» Articles » PMID: 31319788

Cerebral Salt Wasting in a Patient with Myeloproliferative Neoplasm

Overview
Journal BMC Neurol
Publisher Biomed Central
Specialty Neurology
Date 2019 Jul 20
PMID 31319788
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cerebral salt wasting (CSW) is a rare metabolic disorder with severe hyponatremia and volume depletion usually caused by brain injury like trauma, cerebral lesion, tumor or a cerebral hematoma. The renal function is normal with excretion of very high amounts of sodium in the urine. Diagnosis is made by excluding other reasons for hyponatremia, mainly the syndrome of inappropriate antidiuretic hormone secretion (SIADH).

Case Presentation: A 60-year-old patient was admitted to the emergency room with pain in the upper abdomen and visual disturbance two weeks after knee replacement. The patient was confused with severe hematoma at the site of the knee endoprosthesis. Laboratory values showed massive thrombocytosis, leukocytosis, anemia, severe hyponatremia and no evidence of infection. CT scan of the abdomen was inconspicuous. Head MRI showed no ischemia or bleeding, but a mild microangiopathy. A myeloproliferative neoplasm (MPN) was suspected and confirmed by bone marrow biopsy. Cerebral salt wasting syndrome was identified as the cause of severe hyponatremia most likely provoked by cerebral microcirculatory disturbance. The hematoma at the operation site was interpreted as a result of a secondary von Willebrand syndrome (vWS) due to the myeloproliferative neoplasm with massive thrombocytosis. After starting cytoreductive therapy with hydroxycarbamide, thrombocytosis and blood sodium slowly improved along with normalization of his mental condition.

Conclusion: To the best of our knowledge this is the first description of a patient with CSW most likely caused by a microcirculatory disturbance due to a massive thrombocytosis in the context of a myeloproliferative neoplasm.

Citing Articles

Suspected medullary washout leading to severe polyuria following delayed cerebral ischemia: a case report.

Sene P, Gebai A, Kopel T, Cailhier J, Lafrance D, Cote J BMC Nephrol. 2023; 24(1):257.

PMID: 37658303 PMC: 10472600. DOI: 10.1186/s12882-023-03281-4.


Hyponatremia in Patients with Hematologic Diseases.

Koumpis E, Florentin M, Hatzimichael E, Liamis G J Clin Med. 2020; 9(11).

PMID: 33228240 PMC: 7699475. DOI: 10.3390/jcm9113721.

References
1.
Maesaka J, Gupta S, Fishbane S . Cerebral salt-wasting syndrome: does it exist?. Nephron. 1999; 82(2):100-9. DOI: 10.1159/000045384. View

2.
Singh S, Bohn D, Carlotti A, Cusimano M, Rutka J, Halperin M . Cerebral salt wasting: truths, fallacies, theories, and challenges. Crit Care Med. 2002; 30(11):2575-9. DOI: 10.1097/00003246-200211000-00028. View

3.
Palmer B . Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab. 2003; 14(4):182-7. DOI: 10.1016/s1043-2760(03)00048-1. View

4.
Palmer B, Gates J, Lader M . Causes and management of hyponatremia. Ann Pharmacother. 2003; 37(11):1694-702. DOI: 10.1345/aph.1D105. View

5.
Peters J, Welt L, SIMS E, ORLOFF J, Needham J . A salt-wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians. 1950; 63:57-64. View